• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Emerging structural biology of lipid G protein-coupled receptors.脂质 G 蛋白偶联受体的新兴结构生物学。
Protein Sci. 2019 Feb;28(2):292-304. doi: 10.1002/pro.3509.
2
Relevance of rhodopsin studies for GPCR activation.视紫红质研究对G蛋白偶联受体激活的相关性。
Biochim Biophys Acta. 2014 May;1837(5):674-82. doi: 10.1016/j.bbabio.2013.09.002. Epub 2013 Sep 13.
3
G protein-coupled receptors--recent advances.G蛋白偶联受体——最新进展
Acta Biochim Pol. 2012;59(4):515-29. Epub 2012 Dec 18.
4
Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.激动剂诱导的牛视紫红质构象变化:深入了解G蛋白偶联受体的激活
J Mol Biol. 2008 Oct 3;382(2):539-55. doi: 10.1016/j.jmb.2008.06.084. Epub 2008 Jul 7.
5
Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.同源建模辅助分子对接在 G 蛋白偶联受体中的效率。
Curr Top Med Chem. 2021;21(4):269-294. doi: 10.2174/1568026620666200908165250.
6
X-ray structure breakthroughs in the GPCR transmembrane region.G蛋白偶联受体跨膜区域的X射线结构突破。
Biochem Pharmacol. 2009 Jul 1;78(1):11-20. doi: 10.1016/j.bcp.2009.02.012. Epub 2009 Feb 27.
7
The impact of cryo-EM on determining allosteric modulator-bound structures of G protein-coupled receptors.冷冻电镜对确定 G 蛋白偶联受体变构调节剂结合结构的影响。
Curr Opin Struct Biol. 2023 Apr;79:102560. doi: 10.1016/j.sbi.2023.102560. Epub 2023 Feb 26.
8
Molecular signatures of G-protein-coupled receptors.G 蛋白偶联受体的分子特征。
Nature. 2013 Feb 14;494(7436):185-94. doi: 10.1038/nature11896.
9
Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.肾上腺素能受体中配体结合及特异性的结构基础:对G蛋白偶联受体靶向药物发现的启示
Biochemistry. 2008 Oct 21;47(42):11013-23. doi: 10.1021/bi800891r. Epub 2008 Sep 27.
10
GPCR crystal structures: Medicinal chemistry in the pocket.G蛋白偶联受体晶体结构:口袋中的药物化学
Bioorg Med Chem. 2015 Jul 15;23(14):3880-906. doi: 10.1016/j.bmc.2014.12.034. Epub 2014 Dec 24.

引用本文的文献

1
Optimization of the prostaglandin F2α receptor for structural biology.用于结构生物学的前列腺素F2α受体的优化
PLoS One. 2025 Jul 18;20(7):e0320114. doi: 10.1371/journal.pone.0320114. eCollection 2025.
2
Structural insights into lipid chain-length selectivity and allosteric regulation of FFA2.对游离脂肪酸受体2(FFA2)脂质链长选择性和变构调节的结构见解
Nat Commun. 2025 Mar 26;16(1):2809. doi: 10.1038/s41467-025-57983-4.
3
Bitter taste receptor activation by cholesterol and an intracellular tastant.胆固醇和细胞内味觉配体激活苦味受体
Nature. 2024 Apr;628(8008):664-671. doi: 10.1038/s41586-024-07253-y. Epub 2024 Apr 10.
4
Analytical challenges in omics research on asthma and allergy: A National Institute of Allergy and Infectious Diseases workshop.组学研究哮喘和过敏的分析挑战:美国过敏和传染病研究所研讨会。
J Allergy Clin Immunol. 2024 Apr;153(4):954-968. doi: 10.1016/j.jaci.2024.01.014. Epub 2024 Jan 29.
5
The Leu/Val Side Chain of Cannabinoid Receptors Regulates the Binding Mode of the Alkyl Chain of Δ-Tetrahydrocannabinol.大麻素受体亮氨酸/缬氨酸侧链调节Δ-四氢大麻酚烷基链的结合模式。
J Chem Inf Model. 2023 Sep 25;63(18):5927-5935. doi: 10.1021/acs.jcim.3c01054. Epub 2023 Aug 29.
6
Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain.变构调节结合到其细胞外结构域的纳米体对 rhodopsin 的结构基础。
Nat Commun. 2023 Aug 25;14(1):5209. doi: 10.1038/s41467-023-40911-9.
7
Analysis of the mechanism of propagated sensation along meridians based on gene expression profiles.基于基因表达谱分析经络循经感传的机制
J Tradit Complement Med. 2023 Jan 6;13(3):236-244. doi: 10.1016/j.jtcme.2023.01.004. eCollection 2023 May.
8
Covalent cannabinoid receptor ligands - structural insight and selectivity challenges.共价大麻素受体配体——结构洞察与选择性挑战。
RSC Med Chem. 2022 Apr 4;13(5):497-510. doi: 10.1039/d2md00006g. eCollection 2022 May 25.
9
Structures of oxysterol sensor EBI2/GPR183, a key regulator of the immune response.氧化固醇传感器 EBI2/GPR183 的结构,它是免疫反应的关键调节剂。
Structure. 2022 Jul 7;30(7):1016-1024.e5. doi: 10.1016/j.str.2022.04.006. Epub 2022 May 9.
10
Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery.A类脂质G蛋白偶联受体的结构、功能与药理学研究进展:药物研发的机遇与挑战
Pharmaceuticals (Basel). 2021 Dec 22;15(1):12. doi: 10.3390/ph15010012.

本文引用的文献

1
Crystal structure of misoprostol bound to the labor inducer prostaglandin E receptor.米索前列醇与诱导分娩的前列腺素 E 受体结合的晶体结构。
Nat Chem Biol. 2019 Jan;15(1):11-17. doi: 10.1038/s41589-018-0160-y. Epub 2018 Dec 3.
2
Mechanisms of signalling and biased agonism in G protein-coupled receptors.G 蛋白偶联受体信号转导和偏激动机制。
Nat Rev Mol Cell Biol. 2018 Oct;19(10):638-653. doi: 10.1038/s41580-018-0049-3.
3
Structural insights into G-protein-coupled receptor allostery.G 蛋白偶联受体变构的结构见解。
Nature. 2018 Jul;559(7712):45-53. doi: 10.1038/s41586-018-0259-z. Epub 2018 Jul 4.
4
Structure of the adenosine-bound human adenosine A receptor-G complex.人源腺苷受体-G 复合物结合腺苷的结构。
Nature. 2018 Jun;558(7711):559-563. doi: 10.1038/s41586-018-0236-6. Epub 2018 Jun 20.
5
Structural basis for signal recognition and transduction by platelet-activating-factor receptor.血小板激活因子受体信号识别与转导的结构基础。
Nat Struct Mol Biol. 2018 Jun;25(6):488-495. doi: 10.1038/s41594-018-0068-y. Epub 2018 May 28.
6
Structural basis for GPR40 allosteric agonism and incretin stimulation.GPR40 变构激动剂和肠降血糖素刺激的结构基础。
Nat Commun. 2018 Apr 25;9(1):1645. doi: 10.1038/s41467-017-01240-w.
7
A Possible Role for Platelet-Activating Factor Receptor in Amyotrophic Lateral Sclerosis Treatment.血小板活化因子受体在肌萎缩侧索硬化症治疗中的潜在作用。
Front Neurol. 2018 Feb 6;9:39. doi: 10.3389/fneur.2018.00039. eCollection 2018.
8
Structure and dynamics of GPCR signaling complexes.G 蛋白偶联受体信号复合物的结构与动力学
Nat Struct Mol Biol. 2018 Jan;25(1):4-12. doi: 10.1038/s41594-017-0011-7. Epub 2018 Jan 8.
9
Na-mimicking ligands stabilize the inactive state of leukotriene B receptor BLT1.拟钠肽配体稳定白三烯 B 受体 BLT1 的无活性状态。
Nat Chem Biol. 2018 Mar;14(3):262-269. doi: 10.1038/nchembio.2547. Epub 2018 Jan 8.
10
Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity.人类巨噬细胞会根据细菌致病性差异产生特定的消退素或白三烯信号。
Nat Commun. 2018 Jan 4;9(1):59. doi: 10.1038/s41467-017-02538-5.

脂质 G 蛋白偶联受体的新兴结构生物学。

Emerging structural biology of lipid G protein-coupled receptors.

机构信息

Departments of Biological Sciences and Chemistry, Bridge Institute, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, California, 90089.

出版信息

Protein Sci. 2019 Feb;28(2):292-304. doi: 10.1002/pro.3509.

DOI:10.1002/pro.3509
PMID:30239054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6319753/
Abstract

The first crystal structure of a G protein-coupled receptor (GPCR) was that of the bovine rhodopsin, solved in 2000, and is a light receptor within retina rode cells that enables vision by transducing a conformational signal from the light-induced isomerization of retinal covalently bound to the receptor. More than 7 years after this initial discovery and following more than 20 years of technological developments in GPCR expression, stabilization, and crystallography, the high-resolution structure of the adrenaline binding β -adrenergic receptor, a ligand diffusible receptor, was discovered. Since then, high-resolution structures of more than 53 unique GPCRs have been determined leading to a significant improvement in our understanding of the basic mechanisms of ligand-binding and ligand-mediated receptor activation that revolutionized the field of structural molecular pharmacology of GPCRs. Recently, several structures of eight unique lipid-binding receptors, one of the most difficult GPCR families to study, have been reported. This review presents the outstanding structural and pharmacological features that have emerged from these new lipid receptor structures. The impact of these findings goes beyond mechanistic insights, providing evidence of the fundamental role of GPCRs in the physiological integration of the lipid signaling system, and highlighting the importance of sustained research into the structural biology of GPCRs for the development of new therapeutics targeting lipid receptors.

摘要

第一个 G 蛋白偶联受体 (GPCR) 的晶体结构是牛视紫红质的结构,于 2000 年被解析,它是视网膜棒状细胞中的一种光受体,通过将光诱导的视黄醛与受体的共价结合的异构化引起的构象信号转导来实现视觉。在这一初步发现之后的 7 年多时间里,经过 20 多年的 GPCR 表达、稳定化和晶体学技术发展,可扩散配体的肾上腺素结合β-肾上腺素能受体的高分辨率结构被发现。从那时起,已经确定了超过 53 种独特的 GPCR 的高分辨率结构,这极大地促进了我们对配体结合和配体介导的受体激活基本机制的理解,从而彻底改变了 GPCR 的结构分子药理学领域。最近,已经报道了八个独特的脂质结合受体的几个结构,这是最难研究的 GPCR 家族之一。本文综述了这些新的脂质受体结构中出现的突出的结构和药理学特征。这些发现的影响超出了机制方面的见解,为 GPCR 在脂质信号系统的生理整合中的基本作用提供了证据,并强调了持续研究 GPCR 的结构生物学对于开发针对脂质受体的新型治疗方法的重要性。